AU1923501A - Pyridinones to treat and prevent bacterial infections - Google Patents

Pyridinones to treat and prevent bacterial infections

Info

Publication number
AU1923501A
AU1923501A AU19235/01A AU1923501A AU1923501A AU 1923501 A AU1923501 A AU 1923501A AU 19235/01 A AU19235/01 A AU 19235/01A AU 1923501 A AU1923501 A AU 1923501A AU 1923501 A AU1923501 A AU 1923501A
Authority
AU
Australia
Prior art keywords
pyridinones
treat
bacterial infections
prevent bacterial
prevent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU19235/01A
Inventor
Fredrik Almqvist
Hans Emtenas
Scott J. Hultgren
Jerome S. Pinkner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Washington University in St Louis WUSTL
Original Assignee
University of Washington
Washington University in St Louis WUSTL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Washington, Washington University in St Louis WUSTL filed Critical University of Washington
Publication of AU1923501A publication Critical patent/AU1923501A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/04—1,3-Thiazines; Hydrogenated 1,3-thiazines
    • C07D279/06—1,3-Thiazines; Hydrogenated 1,3-thiazines not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pyridine Compounds (AREA)
AU19235/01A 1999-11-19 2000-11-20 Pyridinones to treat and prevent bacterial infections Abandoned AU1923501A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16662199P 1999-11-19 1999-11-19
US60166621 1999-11-19
PCT/US2000/031879 WO2001036426A1 (en) 1999-11-19 2000-11-20 Pyridinones to treat and prevent bacterial infections

Publications (1)

Publication Number Publication Date
AU1923501A true AU1923501A (en) 2001-05-30

Family

ID=22604044

Family Applications (1)

Application Number Title Priority Date Filing Date
AU19235/01A Abandoned AU1923501A (en) 1999-11-19 2000-11-20 Pyridinones to treat and prevent bacterial infections

Country Status (4)

Country Link
EP (1) EP1233967A4 (en)
AU (1) AU1923501A (en)
CA (1) CA2390658A1 (en)
WO (1) WO2001036426A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10215336A1 (en) * 2002-03-28 2003-10-23 Schering Ag New S-protected N-methyl homocysteines useful as intermediates for peptide synthesis
US7262211B2 (en) 2001-12-04 2007-08-28 Dendreon Corporation Aromatic heterocyclic non-covalent inhibitors of urokinase and blood vessel formation
DE10348022A1 (en) * 2003-10-15 2005-05-25 Imtm Gmbh New dipeptidyl peptidase IV inhibitors for the functional influence of different cells and for the treatment of immunological, inflammatory, neuronal and other diseases
CN102066385A (en) * 2008-04-30 2011-05-18 弗雷德里克·阿尔姆奎斯特 New peptidomimetic compounds
TW201130854A (en) 2009-12-22 2011-09-16 Bayer Schering Pharma Ag Pyridinone derivatives and pharmaceutical compositions thereof
WO2016075296A1 (en) * 2014-11-13 2016-05-19 Quretech Bio Ab 2,3-dihydro-thiazolo[3,2-a]pyridin-5-one derivatives, intermediates thereof, and their use as antibacerial agents
KR20180126511A (en) * 2016-04-08 2018-11-27 큐어테크 바이오 에이비 Ring-fused thiazolidino-2-pyridone, its preparation and its use in the treatment and / or prevention of tuberculosis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD84850A (en) *
US4594431A (en) * 1983-08-01 1986-06-10 Eli Lilly Company Octahydroindolizinepropanoic acids and related compounds as enzyme inhibitors

Also Published As

Publication number Publication date
EP1233967A1 (en) 2002-08-28
CA2390658A1 (en) 2001-05-25
EP1233967A4 (en) 2003-07-09
WO2001036426B1 (en) 2001-12-06
WO2001036426A1 (en) 2001-05-25

Similar Documents

Publication Publication Date Title
AU2001268564A1 (en) Alpha-glycosylceramides for treating bacterial and fungal infections
AU2001227930A1 (en) Clostridial toxin derivatives and methods for treating pain
AU2001273406A1 (en) Clostridial toxin derivatives and methods for treating pain
AU3620600A (en) Skin-marking devices and their use
AU7065200A (en) Putting improvement devices and methods
AU3862600A (en) Multifonctional laminate structure and process
AU1890599A (en) Novel microorganism and use thereof
AU5089400A (en) Arthritis treatment
AU2001232647A1 (en) Methods and devices for treating stuttering problems
AU715620C (en) Therapeutic methods and uses
AU1169001A (en) Ferrofluid composition and process
AU7097800A (en) Water treatment systems and methods
AU8037900A (en) Modular processing devices and methods of use
AU7598000A (en) Antimicrobial topical composition and methods
AU1923501A (en) Pyridinones to treat and prevent bacterial infections
AU5547000A (en) Novel treatment
AU1083501A (en) Antibiotic-metal complex and methods
AU4556800A (en) Novel treatment
AU1715100A (en) Biochemically enhanced thermophilic treatment process
AU1772299A (en) Well treatment with microorganisms
AUPQ248399A0 (en) Plant and product treatment
AU5979300A (en) Angiopoietin-6 and uses thereof
AU1735101A (en) Oil-degrading microorganism and utilization thereof
AU4547600A (en) Bacterial culture
AU2003290506A1 (en) Methods and devices for treating severe peripheral bacterial infections

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase